A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer (TNBC)
Interventions: DRUG: TQB2450 Injection and Anlotinib Hydrochioride Capsules
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.